These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11906968

  • 1. Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit.
    Rossoni G, Muscara MN, Cirino G, Wallace JL.
    Br J Pharmacol; 2002 Mar; 135(6):1540-6. PubMed ID: 11906968
    [Abstract] [Full Text] [Related]

  • 2. Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit.
    Rossoni G, Berti M, Colonna VD, Bernareggi M, Del Soldato P, Berti F.
    Ital Heart J; 2000 Feb; 1(2):146-55. PubMed ID: 10730616
    [Abstract] [Full Text] [Related]

  • 3. Aspirin, but not the more selective cyclooxygenase (COX)-2 inhibitors meloxicam and SC 58125, aggravates postischaemic cardiac dysfunction, independent of COX function.
    Heindl B, Becker BF.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):233-40. PubMed ID: 11218076
    [Abstract] [Full Text] [Related]

  • 4. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
    Wallace JL, Zamuner SR, McKnight W, Dicay M, Mencarelli A, del Soldato P, Fiorucci S.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
    [Abstract] [Full Text] [Related]

  • 5. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC.
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [Abstract] [Full Text] [Related]

  • 6. Cyclo-oxygenase-2 inhibition and exacerbation of myocardial dysfunction--protection with nitric oxide?
    Letts G.
    Br J Pharmacol; 2002 Mar; 135(6):1345-6. PubMed ID: 11906945
    [No Abstract] [Full Text] [Related]

  • 7. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart.
    Faghihi M, Mirershadi F, Dehpour AR, Bazargan M.
    Eur J Pharmacol; 2008 Nov 12; 597(1-3):57-63. PubMed ID: 18789320
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
    Itoh T, Haruna M, Abe K.
    Exp Physiol; 2007 Jan 12; 92(1):147-59. PubMed ID: 17030559
    [Abstract] [Full Text] [Related]

  • 13. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA, Warner TD, Vojnovic I, Del Soldato P, Parikh A, Scadding GK, Mitchell JA.
    Br J Pharmacol; 2002 Dec 12; 137(7):1031-8. PubMed ID: 12429575
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.
    Fabi F, Calabrese R, Stati T, del Basso P.
    Br J Pharmacol; 2001 Oct 12; 134(4):777-88. PubMed ID: 11606318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
    Weir MR, Sperling RS, Reicin A, Gertz BJ.
    Am Heart J; 2003 Oct 12; 146(4):591-604. PubMed ID: 14564311
    [Abstract] [Full Text] [Related]

  • 18. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart.
    Xu D, Zhang S, Foster DJ, Wang J.
    Clin Exp Pharmacol Physiol; 2007 Oct 12; 34(5-6):488-93. PubMed ID: 17439420
    [Abstract] [Full Text] [Related]

  • 19. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S, Santucci L, Distrutti E.
    Dig Liver Dis; 2007 Dec 12; 39(12):1043-51. PubMed ID: 17997373
    [Abstract] [Full Text] [Related]

  • 20. Selective cyclo-oxygenase-2 inhibitors: cardiovascular and gastrointestinal toxicity.
    Wallace JL, Muscará MN.
    Dig Liver Dis; 2001 Dec 12; 33 Suppl 2():S21-8. PubMed ID: 11827359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.